Skip to main
AXGN

AxoGen (AXGN) Stock Forecast & Price Target

AxoGen (AXGN) Analyst Ratings

Based on 9 analyst ratings
Strong Buy
Strong Buy 56%
Buy 44%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Axogen is a promising company with a strong market position, potential for growth and profitability. Their cash position, successful sales growth and expansion into new markets make them a sound investment opportunity. However, investors should be aware of potential risks and the possibility of the need for additional financing.

Bears say

Axogen is a leader in peripheral nerve repair with strong growth potential and a diverse portfolio of clinically approved products. However, competition in the market may put pressure on pricing, and the company's trajectory in the urology market is still unproven and uncertain. While their products have potential, it remains to be seen if Axogen can sustain its high growth rate and achieve profitability in the coming years.

AxoGen (AXGN) has been analyzed by 9 analysts, with a consensus rating of Strong Buy. 56% of analysts recommend a Strong Buy, 44% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AxoGen and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AxoGen (AXGN) Forecast

Analysts have given AxoGen (AXGN) a Strong Buy based on their latest research and market trends.

According to 9 analysts, AxoGen (AXGN) has a Strong Buy consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $47.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $47.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AxoGen (AXGN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.